You Searched For "sanofi" and got 17 results
Sort By:
Sanofi board approves demerger of its consumer healthcare business
Drug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer health…
PTI
Sanofi walked back a promise to give the US priority access to its coronavirus vaccine after outrage from the French government
CEO Paul Hudson previously said the US "has the right" to its potential vaccine because it had cont…
Bill Bostock
French drugmaker Sanofi has just invested $59 million in biotech investor Jeito Capital to fund innovation in the biopharma pipeline
Sanofi, one of the world's biggest pharmaceutical companies, has invested €50 million in new French…
Theo Golden,Dr. Catherine Sch…
Translate Bio soars 30% after Sanofi agrees to buy the mRNA company for $3.2 billion
The deal represents a 56% premium to Translate Bio's volume-weighted average price per share over t…
Matthew Fox
Sanofi and Boehringer Ingelheim seek CCI’s clearance for global asset swap deal worth $25 billion
The companies filed their applications to CCI late last week, stating that their mutual transfers, …
Medivation just rejected Sanofi's $9.3 billion takeover bid
"Sanofi's opportunistically-timed proposal, which comes during a period of significant market dislo…
Lydia Ramsey
The new CEO at Sanofi just announced massive changes to the company. 6 slides reveal where the pharma giant is headed now.
The company is stepping back from diabetes and cardiovascular research, Hudson said, citing concern…
Lydia Ramsey
The US would be the first to get a potential coronavirus vaccine being created by a French company, its CEO said
The CEO of Sanofi told Bloomberg the United States would be first because it was the earliest to fu…
Bryan Pietsch
Sanofi just got its first cancer drug approved in a decade. Here's the pharma giant's plan to rejoin the fight against cancer under new CEO Paul Hudson.
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…
Andrew Dunn
GSK and Sanofi delay the expected rollout of their COVID-19 vaccine until late 2021 because of an insufficient response in older people. The US has ordered 100 million doses.
The pharmaceutical giants GlaxoSmithKline and Sanofi said they'd improve their formulation and star…
Grace Dean
Pharma giant Sanofi is developing a vaccine to fight the deadly coronavirus outbreak using its previous research on SARS
The French pharma giant has begun researching a vaccine to counteract the ongoing coronavirus outbr…
Andrew Dunn
Drugmakers Sanofi and GSK launch human trials for COVID-19 vaccine
The major European drug companies have begun testing their coronavirus vaccine on humans in the US …
Kate Duffy
The coronavirus vaccine from Sanofi and GlaxoSmithKline will receive up to $2.1 billion from Operation Warp Speed — here's how it compares to other candidates
Sanofi recently moved up the date of its first clinical trial to September. Companies like Moderna'…
Aria Bendix
Sanofi, GSK come together to develop vaccine for COVID-19
The use of an adjuvant can be of particular importance in a pandemic situation since it may reduce…
PTI
Sanofi joins hands with US govt to expedite development of coronavirus vaccine
In December 2019, Sanofi had also entered into an agreement with BARDA to establish facilities in …
PTI
Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shot
The two vaccine-making giants plan to launch a 35,000-person study in the next few weeks, aiming to…
Andrew Dunn
India's drug controller grants approval to Sanofi and Glaxo Smith Kline to conduct Phase-3 trials of their COVID-19 vaccine
The global, randomised, double-blind Phase-III study will include more than 35,000 volunteers ag…